Age-related macular degeneration (AMD) is an insidious progressive loss of visual function that occurs with aging, and is the leading cause of visual loss in the Western Hemisphere in the elderly.
Vitreomacular Adhesions
Vitreomacular adhesion (VMA) defines a condition in which the vitreous gel and posterior hyaloid are abnormally adherent to the retina. When a posterior vitreous detachment (PVD) is incomplete and does not undergo a normal synchronous sequence of synchisis and syneresis, a taut anterior/posterior traction on the underlying macula can be created. 3, 4 This leads to vitreomacular traction (VMT) and subsequent visual degradation, now identifiable and characterizable on a more regular basis through advances in time-and spectral-domain optical coherence tomography (OCT) imaging. 5, 6 More commonly, traction can lead to a spectrum of retinal architectural distortions, ranging from cystoid macular edema, epiretinal membrane (ERM), and macular holes up to macular and retinal pigment epithelium (RPE) detachments.
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Vitreomacular Adhesions and Age-related Macular Degeneration
The current prevalence of tractional maculopathy is estimated to be 6.4 % within the American population over the age of 50. Recent data have corroborated previous ultrasound findings that incomplete abnormal PVD is more common than was previously thought and that associated posterior VMA seems to be more common among patients with AMD than in age-matched controls, placing prevalence at 22-36 %. [8] [9] [10] [11] In particular, this seems to be the case more often in advanced exudative cases than in patients with non-exudative AMD. 8, [10] [11] [12] [13] Frequently, vitreous attachment sites to the macula correspond to areas of choroidal neovascularization (CNV), suggesting a direct relationship. 4, 8 Mojana and colleagues imaged VMA in AMD, showing a 27.8 % prevalence in exudative cases and 24.5 % in non-exudative cases. In this study, traction was identified on OCT in 59 % and 13 % of patients in each group, respectively, showing a strong direct correlation between adhesion and traction. 12 These abnormal vitreomacular interactions in AMD seem to be present in different populations in the world. In a cohort of Brazilian patients of 204 eyes with AMD imaged with time-domain OCT, 16.7 % had VMT, 7.8 % had ERM, 1 % had macular holes, and 15.2 % had incomplete perifoveal PVD. 14 When using spectral domain OCT imaging, the number of patients with VMA identified may increase up to 73 %. 15 Given that patients with AMD have a higher likelihood of partial PVD, it is often difficult to tell whether their hypertrophy, forming gliotic scars such as the disciform scars seen in late exudative AMD (see Figure 5 ). 39 Figure 5) . 20 The presence of localized macular ischemia, oxidative stress, and chronic inflammation also disturbs the expression of the major potassium channel Figure 6 ). 54 Another study of ILM-denuded pig retinas showed intact underlying
Müller cell membranes. 48 Both studies confirm that, in a normal eye, the ILM is separate from the underlying retina. In AMD, ultrastructural analyses of ERM with VMT showed that there is incorporation of Müller and glial elements into the ILM, with the presence of a fibrocellular multilayer interposed with vitreous collagen and directly on the ILM with predominant myofibroblasts. 45 This corroborates the role that Müller and astrocyte glial cells have in reactive gliosis and traction, as previously stated (see Figure 7 ).
Macular Holes and Age-related Macular Degeneration
Macular holes in AMD arise from the same tractional pathologies that are active in ERM and AMD, and can be considered a progression and more severe clinical manifestation of the VMA forces at work in AMD (see Figure 8 ). In addition, tangential forces across the gap shown to be related to ERM and newly synthesized collagen fibrils within the cortical vitreous are also involved. [55] [56] [57] Post-mortem specimens of macular holes often show the presence of subtle pre-and epi-retinal membranes in 30-73 % of cases. 58 This presence is no coincidence and the membranes are thought to evolve from gliotic reactions and to have an essential role in macular hole dynamics. 59 Perpendicular focal anterior attachments
Tractional Maculopathies in Age-related Macular Degeneration have been shown on OCT, supporting the important role that vitreous traction has in the formation of macular holes. 60 In addition, the alignment of the perifoveal Müller cells is also perpendicular, suggesting that the macular hole stages, as previously described by Gass, are initiated at the stage I level by inner retina layer Müller cell involvement. 6 There is possibly an initial inherent inner retinal weakness and pseudocyst formation that is compounded by focal Müller glial cell proliferation in an unsuccessful attempt to repair and bridge the gap, creating secondary traction as cells migrate around the perifoveal denuded ILM.
Management of Age-related Macular Degeneration and Vitreomacular Adhesion
Given that anomalous and partial PVD might have an important role in AMD progression, prophylactic surgical and pharmacologic methods of traction release can be considered as an additional part of the treatment for AMD to improve retinal distortion. However, limited data (case reports, small case series, short follow-up) are available on surgical outcomes of tractional maculopathies in patients with AMD. OCT has revolutionized the detection of previously unrecognized cases of VMT and is now an indispensable tool in all cases of combined diagnoses. 6 
Pars plana vitrectomy
Pars plana vitrectomy (PPV) continues to be the mainstay treatment in releasing the traction on the retina induced by vitreomacular adhesions. 61, 62 Some researchers have postulated that PPV, as a form of artificial PVD alone, might be sufficient to simulate its beneficial effects in AMD.
Alternately, vitrectomy might be beneficial through the release of tractional damages that ultimately lead to RPE atrophy, the reduction of inflammatory mediators from the milieu, and the provision of a higher oxygen diffusion environment in areas that have localized ischemia. In addition, ILM peeling to remove the scaffold for glial and myofibroblast cell migration into the vitreoretinal interface has also been advocated, as many authors have found this to correlate with higher anatomical and functional success in macular hole and ERM surgery, and lower recurrence rates. 57, 58, 63 To facilitate visualization during surgery, the use of intravitreal vital dyes, such as Trypan blue, triamcinolone acetonide, indocyanine green, and more recently brilliant blue, is encouraged for staining the ERM and ILM. However, the risks of using these dyes in the presence of concomitant tractional maculopathies and AMD are unknown and therefore should be used with caution. In addition, endotamponade with an intraocular gas is recommended to ensure long-term surgical success after vitrectomy and membrane peeling for macular holes. 
Anti-Vascular Endothelial Growth Factor
Diseases that might be amenable to anti-VEGF treatment should also receive intravitreal injections first, as a concurrent vitrectomy might decrease the vitreous half-lives of such agents. Both ranibizumab and bevacizumab have been used as first line treatments in combined cases of AMD and VMT, although extended treatment is warranted to control exudative recurrences (see Figure 8) . 17 Interestingly, traction often worsens clinically and on imaging following intravitreal injections (IVI) and even macular holes have been described after anti-VEGF injection for exudative AMD. tension, it appears that post-operative trauma and the surgical sequelae on the RPE may overpower the beneficial effects of surgery to incite neovascularization. [72] [73] [74] [75] [76] [77] [78] [79] This was the case in our small gauge vitrectomy series as described above, where the sole patient whose visual acuity did not improve was due to the result of development of de novo CNV post 25-ga vitrectomy for ERM removal (see Figure 9 ).
Figure 7: Illustration of Reactive Gliosis in Age-related Macular Degeneration

A: The normal retinal microarchitecture highlighting only the retinal pigment epithelium (RPE) (brown), Müller cells (yellow), astrocytes (silver), retinal blood vessels (red), and inner limiting membrane (ILM) (transparent grey). B: Dry AMD with a close-up of drusen accumulation under the RPE and the proximity of Müller cells (yellow) over the RPE. C: Drusen inflammatory and oxidative stress (red staining of RPE and Müller cells) stimulus. D: Consequent reactive gliosis with Müller cells (orange) and astrocytes migration towards the ILM vitreal side. E: epiretinal membrane formation in dry AMD.
Management techniques advocate the sequential treatment of the CNV first followed by surgical hole repair (see Figure 8) . The posited reasoning is that pharmacologic involution of CNV might cause macular hole edges to regress. With these techniques and improved surgical instrumentation, improved visual outcomes can be expected. 76 Photodynamic therapy in conjunction with vitrectomy has also been reported as a successful treatment, despite the evolution of anti-angiogenesis treatments. and tangential forces applied and transmitted to the RPE, leading to mechanisms that make the RPE more susceptible to RPE detachment and tears, and even secondary macular holes. [83] [84] [85] In addition, Chan and colleagues linked PED and RPE tears in a study, where 2,785 injections in 1,064 patients demonstrated an incidence of 2.22 % RPE tears among all AMD eyes and 17.5 % among eyes with previous PED. 86 However, RPE tears after ERM removal in patients with AMD, as seen in two of our own surgical AMD cohort, have previously been unreported (see Figure 10 ).
Previous authors have observed that spontaneous RPE tear can occur in patients with AMD secondary to the underlying PED. 87 The authors suggest that in the absence of obvious predisposing factors, Müller cells and reactive gliosis are an important etiological component by coupling inner and outer retina movements and mechanotransduction forces (see Figure 11 ). It is hypothesized that these biophysical phenomena can account for the creation of an RPE tear in that a mechanically stiffer Müller cell can support the transmission of force from the internal limiting membrane to the outer retina and RPE (see Figure 11 ). The intercalation of Müller cells into adjacent photoreceptor structures predisposes them to the transmission of tractional forces so that when surgical instruments pull on the glial epiretinal and VMA elements, the same force can be transmitted to the outer retina, directly damaging the already weakened and atrophic RPE. Therefore, extreme care must be exercised when performing ERM and ILM peeling in patients with AMD, and RPE tears should be recognized as a possible direct iatrogenic complication of these procedures in patients with dry or exudative AMD (see Figure 10 ). 
Conclusion
